Teplizumab

Is It a Milestone for Type 1 Diabetes or a Risk Factor for Other Autoimmune Diseases in the Long Term?

Ozen, Gulsum
Iafusco, Dario

Regional Centre for Pediatric Diabetes, Department of Pediatrics, University of Campania Luigi Vanvitelli, Naples, Italy

Corresponding author: Gulsum Ozen, [email protected]

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.

Clinical Diabetes 42(2):p 314-315, Spring 2024. | DOI: 10.2337/cd23-0073